• Home  
  • CEIN rewards innovation against pediatric cancer and surgical 3D printing
CEIN rewards innovation against pediatric cancer and surgical 3D printing
- Business

CEIN rewards innovation against pediatric cancer and surgical 3D printing

The quality of the six finalist projects of the Health Accelerator, from CEINdid not let the jury decide on one of them and ended up doubling the 8,000 euros allocated to the winning projectresulting winners Popcorn Therapeuticsa modular system based on genetically modified triple-acting oncolytic adenoviruses to combat lethal pediatric brain tumors, which presented Iker

The quality of the six finalist projects of the Health Accelerator, from CEINdid not let the jury decide on one of them and ended up doubling the 8,000 euros allocated to the winning projectresulting winners Popcorn Therapeuticsa modular system based on genetically modified triple-acting oncolytic adenoviruses to combat lethal pediatric brain tumors, which presented Iker Ausejoy Additive 3D Engineeringbased on the manufacturing by 3D printing of anatomical models and hyper-realistic biomimetic tissues for surgical training and pre-operative planning, presented by Pablo Larumbe and Álvaro Santamaría. Achieving first place in the sixth edition also grants them a direct pass to the next phase of business development (Health Scale Up) and a free six-month stay in the CEIN business incubator.

The virus designed by Popcorn Therapeutics acts as a smart drug: crosses the blood-brain barrier, selectively enters tumor cells and hijacks their internal machinery to produce two immunotherapy drugs. When the body’s own defenses are activated, the tumor is destroyed from within and releases new viruses that continue the cycle. Its objective is to overcome the lack of effectiveness of the palliative chemotherapy and radiotherapy current without causing toxicity in healthy tissues.

In the case of Additive 3D Engineeringusing anonymized medical CT or MRI images processed with AI algorithms in just 20 minutesthe team reproduces exact organs in flexible materials that mimic the texture and behavior of human tissue.

“Innovating means understanding a need well, listening to people and being able to offer a real, viable and sustainable solution,” he said. Juan Luis Garcíaadvisor of University, Innovation and Digital Transformation of the Government of Navarraduring the awards ceremony. The Health Accelerator is a business promotion program specialized in the field of health, supported with financing by the Department of University, Innovation and Digital Transformation of the Government of Navarra, whose main objective is to offer technical training and specialized support to facilitate the development of new biomedical solutions and their differential access to the market.

FOUR IMPACT PROJECTS

Among the others four finalist initiativesproposals were presented that ranged from Neuromuscular diagnosis and advanced immunotherapy to AI-assisted communication and alternative biological assays.

First Assaypresented by Augusto Vargasis a biotechnological platform for preclinical trials with trout eggs and larvae that reduces costs and avoids the use of adult animals in the early stages; Diagnostic Platformdefended by Armando Malandais an electromyographic analysis software with a virtual assistant that speeds up the diagnosis of neuromuscular diseases and increases precision; Communicationexposed by Alejandro Subiran and Gianluca Vetteris an AI-powered application that suggests agile responses to allow people with ALS who have lost their voice to converse in real time; and Cancer immunotherapyled by David Escorsfocuses on new biological drugs (the antibody CB213 and oleuropein) designed for patients who do not respond to current immunological treatments.

Source: www.diariodenavarra.es

About Us

Toolq Media Is a Global News Platform Covering the Latest Developments and Breaking Stories from Around The World, Including World News, Business, Finance, Technology, Health, Politics, Science, Entertainment, Sports, and More.

Toolq

Toolq @2026. All Rights Reserved.